Life Sciences

Silicon Valley has its thriving technology sector. Now, the southern region of I-495 is creating a hotbed...

Natick-based medical device maker Boston Scientific Corp. said it will eliminate 900 to 1,000 jobs worldwide this year in an effort to cut costs after posting a loss of more than $4 billion for 2012.

French pharmaceutical firm Ipsen and its strategic partner, Inspiration Biopharmaceuticals of Cambridge, have agreed to sell their leading hemophilia drug program to Illinois-based Baxter International.

Advanced Cell Technology (ACT) of Marlborough said it has reached a settlement agreement in a lawsuit it faced over the conversion of debt notes and the exercise price of certain warrants.

A Marlborough medical device manufacturer said a trial of its catheter ablation system designed to treat patients with irregular heartbeats is about half enrolled.

Framingham-based medical device maker HeartWare International said it expects full-year revenue for 2012 to come in around $110 million, with about $32 million coming during the fourth quarter.

After receiving approvals and negotiating tax breaks to build a $42-million expansion of subsidiary Biomeasure's Milford facility,...

Framingham-based GTC Biotherapeutics Inc. has changed its name to rEVO Biotherapeutics, it announced.

Hologic Inc. of Bedford, which has operations in Marlborough, announced the sale of its Lifecodes business to Georgia-based Immucor Inc.

A Worcester biotech firm has signed a lease for office and lab space in Marlborough.